The CEO of the pharmaceutical company Pfizer, whose name we have heard often since the beginning of COVID-19, evaluated the current situation of the virus. Pfizer CEO stated that the effect of the virus will be felt for years to come.
Albert Bourla, CEO of the United States-based pharmaceutical company Pfizer, made interesting statements about the COVID-19 virus, evaluating the current situation in a statement to the French television BFMTV. Noting that the existence and impact of the COVID-19 virus will continue for many years, Bourla said, "Because it has spread all over the world, it will not be easy to get rid of."
On the other hand, Bourla stated that he thinks the Omicron variant may be the last wave that requires such drastic restrictions and measures. Regarding this issue, Bourla noted, "I believe that this wave may be the last wave in which such restrictions were made, with the tools developed by science."
A more effective vaccine on the Omicron variant will arrive in 3 months
In his statement, Bourla stated that the first variant that passed the protection provided by 'Pfizer-BioNTech', the COVID-19 vaccine developed by the company, was Omicron. For these studies, Bourla said, "In a very short time, within 3 months, we will have an effective vaccine." conveyed in the form.
In addition, in the statement made by Pfizer, it was stated that the anti-viral drug called 'Paxlovid' developed by the company against COVID-19 will be produced in France. On 16 December, the European Medicines Agency, the drug regulator of the European Union (EU), approved Paxlovid for use in the treatment of COVID-19.
In the statement, it was stated that an investment of 520 million Euros will be made for 5 years for this study.